Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme

Bloomberg2021-06-23

Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing. Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

G3113
2021-06-24
G3113
😊
- G3113:
  😊
- G3113:
  😊
Takiho
2021-06-24
Takiho
Goldman Sach - good to look at, promising share
Radedward
2021-06-24
Radedward
It’s fine when banks do it but suspicious when reddit groups try?
- CSYNCTP06:
  Hi
bzlim
2021-06-24
bzlim
Most definitely contributed to the soar that day but also contributed to the crash. Also known as pump and dump.
SPOT_ON
2021-06-24
SPOT_ON
Power
eric2211
2021-06-24
eric2211
Nice

发表看法

478

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1159107044?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-23 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159107044","market":"us","top_or_hot":-1,"title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","media":"Bloomberg","content":"<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GS","symbol_name":"高盛","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","article_id":"1159107044","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","pubTimestamp":1624459161,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"GS":"高盛"},"translate_title":"高盛在迷因股票Orphazyme中短暂建股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GS":0.9},"content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":128111734,"gmtCreate":1624505583628,"gmtModify":1634005119487,"author":{"id":"3573191001665366","authorId":"3573191001665366","authorIdStr":"3573191001665366","name":"G3113","avatar":"https://static.tigerbbs.com/c97fca7472bab53fc23b5c0445cb7a68","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573191001665366"},"htmlText":"😊","listText":"😊","text":"😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/128111734","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","pubTimestamp":1624459161,"share":"https://www.laohu8.com/m/news/1159107044?lang=&edition=full","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5009166,"gmtCreate":1624597745233,"gmtModify":1635247095915,"authorId":3573191001665366,"author":{"id":3573191001665366,"authorId":3573191001665366,"name":"G3113","avatar":"https://static.tigerbbs.com/c97fca7472bab53fc23b5c0445cb7a68","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":128111734,"type":1,"supId":0,"prevId":0,"content":"😊","text":"😊","html":"😊"},{"id":5009528,"gmtCreate":1624599681392,"gmtModify":1635247060307,"authorId":3573191001665366,"author":{"id":3573191001665366,"authorId":3573191001665366,"name":"G3113","avatar":"https://static.tigerbbs.com/c97fca7472bab53fc23b5c0445cb7a68","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":128111734,"type":1,"supId":0,"prevId":0,"content":"😊","text":"😊","html":"😊"}],"langContent":"EN"},{"id":121744666,"gmtCreate":1624493887155,"gmtModify":1631885284530,"author":{"id":"3586588423230446","authorId":"3586588423230446","authorIdStr":"3586588423230446","name":"Takiho","avatar":"https://static.tigerbbs.com/9c71ba836ffdebd7c9d6c75d4b188cd8","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3586588423230446"},"htmlText":"Goldman Sach - good to look at, promising share&nbsp;","listText":"Goldman Sach - good to look at, promising share&nbsp;","text":"Goldman Sach - good to look at, promising share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121744666","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","pubTimestamp":1624459161,"share":"https://www.laohu8.com/m/news/1159107044?lang=&edition=full","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121751950,"gmtCreate":1624493433670,"gmtModify":1631891133192,"author":{"id":"3586585894056979","authorId":"3586585894056979","authorIdStr":"3586585894056979","name":"Radedward","avatar":"https://static.tigerbbs.com/2f0517067d18531fa857b594c9650d99","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586585894056979"},"htmlText":"It’s fine when banks do it but suspicious when reddit groups try?","listText":"It’s fine when banks do it but suspicious when reddit groups try?","text":"It’s fine when banks do it but suspicious when reddit groups try?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/121751950","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","pubTimestamp":1624459161,"share":"https://www.laohu8.com/m/news/1159107044?lang=&edition=full","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4985995,"gmtCreate":1624497234054,"gmtModify":1631891133194,"authorId":3569978586500313,"author":{"id":3569978586500313,"authorId":3569978586500313,"name":"CSYNCTP06","avatar":"https://static.tigerbbs.com/4fd2aa5c3a3fb737be0567ef3f336a98","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":121751950,"type":1,"supId":0,"prevId":0,"content":"Hi","text":"Hi","html":"Hi"}],"langContent":"EN"},{"id":121788140,"gmtCreate":1624492574280,"gmtModify":1634005432688,"author":{"id":"3572436349218639","authorId":"3572436349218639","authorIdStr":"3572436349218639","name":"bzlim","avatar":"https://static.tigerbbs.com/3b2aafaf14823285f7393917b6ff4f54","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3572436349218639"},"htmlText":"Most definitely contributed to the soar that day but also contributed to the crash. Also known as pump and dump.&nbsp;","listText":"Most definitely contributed to the soar that day but also contributed to the crash. Also known as pump and dump.&nbsp;","text":"Most definitely contributed to the soar that day but also contributed to the crash. Also known as pump and dump.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121788140","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","pubTimestamp":1624459161,"share":"https://www.laohu8.com/m/news/1159107044?lang=&edition=full","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121716792,"gmtCreate":1624492352916,"gmtModify":1631888657905,"author":{"id":"3582922989777578","authorId":"3582922989777578","authorIdStr":"3582922989777578","name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582922989777578"},"htmlText":"Power","listText":"Power","text":"Power","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121716792","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","pubTimestamp":1624459161,"share":"https://www.laohu8.com/m/news/1159107044?lang=&edition=full","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":121458195,"gmtCreate":1624490516917,"gmtModify":1631892539080,"author":{"id":"3587085550299233","authorId":"3587085550299233","authorIdStr":"3587085550299233","name":"eric2211","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3587085550299233"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121458195","repostId":1159107044,"repostType":4,"repost":{"id":"1159107044","pubTimestamp":1624459161,"share":"https://www.laohu8.com/m/news/1159107044?lang=&edition=full","pubTime":"2021-06-23 22:39","market":"us","language":"en","title":"Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159107044","media":"Bloomberg","summary":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according t","content":"<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.</p>\n<p>Orphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.</p>\n<p><img src=\"https://static.tigerbbs.com/87c5b53a8732ab8cba47ac53ffda357d\" tg-width=\"558\" tg-height=\"313\" referrerpolicy=\"no-referrer\"></p>\n<p>Goldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.</p>\n<p>Orphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Briefly Builds Stake in Meme Stock Orphazyme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Briefly Builds Stake in Meme Stock Orphazyme\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-23/goldman-sachs-briefly-builds-stake-in-meme-stock-orphazyme?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159107044","content_text":"Goldman Sachs Group Inc. briefly built, then sold a stake in Denmark’s first meme stock, according to a regulatory filing.\nOrphazyme A/S, a small Danish biotech firm,saidon Wednesday the Wall Street firm had a stake that exceeded the 5% threshold that triggers a filing, and then quickly reduced its holding to below that level last week.\n\nGoldman’s holding was 5.58% as of June 16, and less then 5% a day later. The bank hasn’t previously appeared as an investor in regulatory filings for Orphazyme.\nOrphazyme morphed into a meme stock on June 10. After building a sudden fan base on social media platforms such as Reddit, the company’s American depositary shares soared almost 1,400% at one point during U.S. trading hours. Last week, the stock’s share pricecrashedafter it failed to win regulatory approval for a key treatment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":478,"commentSize":72,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159107044"}